Intuitive Surgical stock gains on new da Vinci approvals

Intuitive Surgical stock gained 6.5 percent on September 22, 2026, after new European approvals expanded the potential use of the da Vinci platform. Intuitive Surgical, Inc. has also reported revenue of USD 3.6 billion in the latest reported period, 34 percent above the year-ago period.

New approvals widen the platform

According to Yahoo Finance on September 22, 2026, Intuitive received CE mark approval for using its da Vinci SP single-port system in transvaginal gynecologic procedures. The approval adds to existing European indications for endoscopic and natural-orifice surgery.

A separate report on the same date said the da Vinci 5 system received European approval for adult cardiac surgery. According to Building Better Healthcare, the cardiac indication broadens the addressable use of the newer system.

Revenue growth remains central

Revenue reached USD 3.6 billion in the latest reported period, according to Mitrade on September 22, 2026. The 34 percent year-over-year increase gives the approval news a financial anchor: wider procedure coverage can support future system placements, instruments and service revenue, but the article does not provide a new company forecast.

Historical context points in the same direction. A September 23, 2026 industry overview reported preliminary fiscal year 2025 revenue of approximately USD 10.06 billion, up 21 percent from USD 8.35 billion in fiscal year 2024, while da Vinci procedures reached approximately 3.15 million, up 18 percent year over year. These fiscal year 2025 figures are historical context rather than a same-day earnings update.

Stock moves with Nasdaq support

The broader Nasdaq Composite closed at 27,244.28 on September 22, 2026, up 0.45 percent, providing a supportive backdrop for large-cap growth stocks. Intuitive Surgical stock had advanced 6.5 percent in the cited September 22 report, linking the market reaction directly to the new da Vinci indications rather than to a separately reported earnings release.

Price and investor perspective

Intuitive Surgical stock closed with a 6.5 percent gain on September 22, 2026, in USD on Nasdaq. The combination of a dated price reaction, a 34 percent revenue comparison and expanded European indications makes procedure growth and adoption the key operating variables for the next report.

More news and analyses on Intuitive Surgical stock